Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Sam Farres, M.D. Vascular Surgeon, Mayo Clinic
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
All About Thoracic Outlet Syndrome (TOS): Recovery and Long-term Outlook
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Navigating the Role of Non-Executive Directors in a Changing Economic and Political Landscape | Steven Fine, CEO, Peel Hunt Ltd.
00:10:00
Sipa Resources Corporate Presentation Highlights
00:10:00
Il Capitale Naturale: Preservazione e Rigenerazione con Lombard Odier Investment Managers
00:10:00
CEO Patrik Emanuelsson on Heba's Vision for Sustainable Real Estate | Patrik Emanuelsson, CEO, Heba Real Estate AB.
00:10:00
AAC Technologies Group Publicity | Pan Zhengmin, CEO, AAC Technologies Holdings Inc2018:HKG
00:10:00
Crescendo Financial Group's Transition to Raymond James: Enhancing Service and Support
00:10:00
Fed Chair Powell Urges Patience Amid Economic Uncertainty, Highlights Risks from Tariffs and Public Sentiment on Inflation|Jerome Powell,Chair,Federal Reserve
00:10:00
Pioneering Drug Development for Inflammation and Cancer | Dr. Thomas Olin, CEO , Kancera AB.
00:10:00
Presentation on Blackstone Minerals: Restarting and Expanding Nickel Operations in Northern Vietnam
00:10:00
Axiom Group: Revolutionizing Mining Exploration with Advanced Technology and Data Integration
00:10:00
Greg Gilbert: Enhancing Institutional Investment through OCIO Services | Greg Gilbert - CEO of Americas Institutional at Russell Investments
00:10:00
Exploring the Shift Towards Energy Efficiency and Collective Self-Consumption in Response to the Energy Crisis | Orazio Iacono, CEO, Hera SpA.